Deutsche Bank’s Journey Medical DERM Stock Holding History

Deutsche Bank’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,560	Closed	-$54.2K	–	3746
2026 Q1	$54.2K	Hold	11,560	–	–	﹤0.01%	3458
2025 Q4	$89.1K	Buy	+11,560	New	+$90.6K	﹤0.01%	3329
2025 Q3	–	Sell	-12,968	Closed	-$93.1K	–	3628
2025 Q2	$93.1K	Buy	+12,968	New	+$89.6K	﹤0.01%	3288

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Deutsche Bank's DERM Position: Q2 2026 in Review

Deutsche Bank sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 11,560 shares — an estimated $54.2K sold.

Deutsche Bank first reported a position in DERM in Q2 2025 and held it in 3 quarters. The position peaked at $93.1K in Q2 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Deutsche Bank reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
Deutsche Bank sold 11,560 Journey Medical shares in Q2 2026, an estimated $54.2K.
Deutsche Bank first reported a position in Journey Medical in Q2 2025 and held it in 3 quarters.
Deutsche Bank's Journey Medical position peaked at $93.1K in Q2 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.